T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model

Transplantation

Volumn 78, Issue 11, 2004, Pages 1609-1617

  Eguchi, Hiroshi ^a   Knosalla, Christoph ^a   Lan, Ping ^a   Cheng, Jane ^b   Diouf, Bintou ^a   Wang, Lan ^a   Abe, Masahiro ^a   Schuurman, Henk Jan ^b   Sachs, David H ^a   Sykes, Megan ^a   Cooper, David K C ^a   Yang, Yong Guang ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Immerge Biotherapeutics Inc   (United States)

Author keywords

Graft versus host disease; Hematopoiesis; Pigs; Xenotransplantation

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; LIPOSOME; MEDRONIC ACID; SNAKE VENOM; T LYMPHOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BONE MARROW CELL; CELL MEDIATED CYTOTOXICITY; CHIMERA; DONOR; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; IMMUNOCOMPETENCE; MIXED LYMPHOCYTE REACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOSENSITIZATION; RECIPIENT; SKIN GRAFT; SKIN SENSITIZATION; SKIN TRANSPLANTATION; SPLEEN CELL; SWINE; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; WHOLE BODY RADIATION; XENOTRANSPLANTATION;

ANIMALS; ANTIBODY FORMATION; CHIMERISM; GRAFT VS HOST DISEASE; MICE; MICE, INBRED BALB C; MICE, SCID; MICE, TRANSGENIC; SKIN TRANSPLANTATION; SWINE; SWINE, MINIATURE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 10644241577     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000142621.52211.79     Document Type: Article

References (42)

1. Sachs DH. The pig as a potential xenograft. Vet Immunol Immunopathol 1999; 43: 187.
2. Cooper DKC, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133.
3. Platt JL. Xenotransplantation: Recent progress and current perspectives. Curr Opin Immunol 1996; 8: 721.
4. Korsgren O. Acute cellular xenograft rejection. Xenotransplantation 1997; 4: 11.
5. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
6. Mayumi H, Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989; 169: 213.
7. Sharabi Y, Aksentijevich I, Sundt TM III, et al. Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
8. Yang YG, deGoma E, Ohdan H, et al. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
9. Huang CA, Fuchimoto Y, Scheier-dolberg R, et al. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173.
10. Spitzer TR, Delmonico F, Tolkoff-Rubin N, et al. Combined histocompatible leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480.
11. Yang YG. Application of xenogeneic stem cells for induction of transplantation tolerance: Present state and further directions. Springer Semin Immunopathol (in press).
12. Abe M, Qi J, Sykes M, et al. Mixed chimerism induces donor-specific T cell tolerance across a highly disparate xenogeneic barrier. Blood 2002; 99: 3823.
13. Lan P, Wang L, Diouf D, et al. Induction of human T cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism. Blood 2004; 103: 3964.
14. van den Brink MR, Burakoff SJ. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol 2002; 2: 273.
15. Chen AM, Zhou Y, Swenson K, et al. Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: Toward tolerance induction across discordant xenogeneic barriers. Transplantation 2000; 69: 2484.
16. Yang YG, Chen AM, Garrett LJ, et al. Development and analysis of transgenic mice expressing porcine hematopoietic cytokines: A model for achieving durable porcine hematopoietic chimerism across an extensive xenogeneic barrier. Xenotransplantation 2000; 7: 58.
17. Yang YG, Chen AM, Sergio JJ, et al. Role of antibody-independent complement activation in rejection of porcine bone marrow cells in mice. Transplantation 2000; 69: 163.
18. Abe M, Cheng J, Qi J, et al. Elimination of porcine hemopoietic cells by macrophages in mice. J Immunol 2002; 168: 621.
19. Yang YG, deGoma E, Barth R, et al. B cell reconstitution and xenoreactive anti-pig natural antibody production in scid mice reconstituted with immunocompetent B cells from varying sources. Transplantation 1998; 66: 89.
20. LeGuern AC, Giovino M, Abe M, et al. Stem cell activity of porcine c-kit+ hematopoietic cells. Exp Hematol 2003; 31: 833.
21. Moses RD, Pierson RN III, Winn HJ, et al. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567.
22. Moses RD, Winn HJ, Auchincloss H Jr. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992; 53: 203.
23. Ohdan H, Yang YG, Swenson KG, et al. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3- galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001; 71: 1532.
24. Aksentijevich I, Sachs DH, Sykes M. Natural antibody against bone marrow cells of a concordant xenogeneic species. J Immunol 1991; 147: 79.
25. Aksentijevich I, Sachs DH, Sykes M. Natural antibodies can inhibit bone marrow engraftment in the rat-mouse species combination. J Immunol 1991; 147: 4140.
26. Serody JS, Burkett SE, Panoskaltsis-Mortari A, et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 2000; 96: 2973.
27. Serody JS, Cook DN, Kirby SL, et al. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood 1999; 93: 43.
28. Panoskaltsis-Mortari A, Hermanson JR, Taras E, et al. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1alpha (CCL3) after allogeneic BMT in mice. Blood 2003; 101: 3714.
29. Warnock RA, Campbell JJ, Dorf ME, et al. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000; 191: 77.
30. Sasaki M, Hasegawa H, Kohno M, et al. Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 2003; 170: 588.
31. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154.
32. Welniak LA, Wang Z, Sun K, et al. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol 2004; 32: 318.
33. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296.
34. Buhler L, Awwad M, Treter S, et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockadel. Transplantation 2002; 73: 12.
35. Hoffmann-Fezer G, Gall C, Zengerle U, et al. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993; 81: 3440.
36. Sandhu JS, Gorczynski R, Shpitz B, et al. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation 1995; 60: 179.
37. Tsuchida M, Brown SA, Tutt LM, et al. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Clin Transplant 1997; 11: 522.
38. Gorin NC, Piantadosi S, Stull M, et al. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/ SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. J Hematother Stem Cell Res 2002; 11: 277.
39. Di Ianni M, Terenzi A, Falzetti F, et al. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice. Cancer Gene Ther 2002; 9: 756.
40. van Rijn RS, Simonetti ER, Hagenbeek A, et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood 2003; 102: 2522.
41. Emery DW, Sykes M, Sachs DH, et al. Mixed swine/human long-term bone marrow cultures. Transplant Proc 1994; 26: 1313.
42. Giovino MA, Hawley RJ, Dickerson WM, et al. Xenogeneic bone marrow transplantation: II. Porcine-specific growth factors enhance porcine bone marrow engraftment in an in vitro primate microenvironment. Xenotransplantation 1997; 4: 112.